Home

Welcome to

CHORD Therapeutics

Drug development for rare neurological diseases



CHORD Therapeutics is a clinical stage biotech incorporated in Geneva, Switzerland.  The company is currently in discussions with investors to provide venture capital for development of CRD1.



MISSION


CHORD Therapeutics is dedicated to repurposing the small molecule drug CRD1, under orphan drug/orphan medicinal product designation, to bring a new effective therapy to patients with life-threatening and severely disabling neurological diseases.




CONTACT

info@chordtherapeutics.com


Last updated: 15 June 2019